Eli Lilly and Company (LLY) Stock Investment Calculator & Historical Return Analysis

Eli Lilly and Company is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. Investors often view Eli Lilly and Company as a key player in the market, analyzing its long-term potential through various revenue models, brand recognition, and consistent presence in its industry.

This Eli Lilly and Company stock investment calculator allows you to explore how a hypothetical investment in LLY might have performed over time. By adjusting the investment amount and time period, you can visualize potential growth, compare outcomes across different market cycles, and better understand the impact of long-term investing.

What if you invested $1000 in LLY on Jan 1, 2020?

Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.

📈
Your investment journey awaits!
Click "Calculate Investment" to see your potential returns
Current Value
$XX,XXX
Return
+XXX%
CAGR
X.XX%
vs SPY
+XX%

Understanding Eli Lilly and Company's Historical Performance

Eli Lilly and Company's stock performance has historically reflected both broader market trends and company-specific milestones. Like many growth-oriented stocks, LLY has experienced periods of growth driven by innovation and market demand.

When analyzing Eli Lilly and Company's historical returns, it's important to consider:

  • Market cycles: Strong bull markets often amplify returns, while recessions can temporarily suppress performance.
  • Business model evolution: Changes in revenue strategies and product lines can significantly impact stability.
  • Long-term trends: Over extended periods, compounding can play a larger role than short-term price fluctuations. Try our calculator to explore returns over 5 years or larger investments over 10 years.

This calculator helps you see how these factors might have affected an investment depending on when you entered the market.

Historical Annual Returns

Over the past 40 years, Eli Lilly and Company has delivered an average annual return of 19.8%. The stock peaked in 1997 with a massive +94.8% gain, while investors faced a downturn in 1992 (-26.1%). Overall, the stock finished in the green 31 times out of 40 years.

Avg Return

+19.8%

Win Rate

78%

31W - 9L

Best

+94.8%

1997

Worst

-26.1%

1992

Performance Consistency

31 Positive9 Negative

Eli Lilly and Company Annual Returns by Year

YearAnnual ReturnStart PriceEnd Price
1986+38.98%$2.36$3.28
1987+7.48%$3.28$3.52
1988+10.34%$3.60$3.98
1989+63.89%$3.98$6.53
1990+9.10%$6.55$7.14
1991+17.80%$7.10$8.36
1992-26.10%$8.50$6.28
1993+1.40%$6.34$6.43
1994+15.63%$6.43$7.44
1995+78.36%$7.40$13.19
1996+34.75%$12.99$17.50
1997+94.85%$17.38$33.86
1998+30.41%$33.53$43.72
1999-21.71%$42.31$33.13
2000+43.92%$32.66$47.00
2001-12.96%$46.21$40.22
2002-17.53%$40.20$33.16
2003+9.69%$34.20$37.51
2004-18.59%$38.00$30.93
2005+3.44%$30.66$31.72
2006-6.45%$32.15$30.08
2007+5.37%$30.16$31.78
2008-20.04%$31.28$25.01
2009-6.93%$25.20$23.45
2010+3.34%$23.52$24.31
2011+25.32%$24.28$30.43
2012+23.53%$30.60$37.80
2013+6.87%$37.95$40.56
2014+40.50%$40.34$56.68
2015+23.48%$57.56$71.08
2016-8.87%$69.90$63.71
2017+16.18%$64.61$75.07
2018+40.09%$75.26$105.43
2019+16.99%$104.67$122.45
2020+30.27%$123.18$160.46
2021+69.43%$157.29$266.49
2022+36.47%$262.16$357.78
2023+61.28%$356.95$575.70
2024+31.21%$584.86$767.41
2025+38.95%$773.44$1074.68

Historical annual returns for Eli Lilly and Company. Data shows year-over-year percentage change in stock price.

Why Use a "What If" Stock Calculator?

Many investors wonder questions such as:

A what-if investment calculator answers these questions by turning historical data into practical insights. Rather than focusing on daily price movements, it encourages a long-term perspective, which is especially useful for retirement planning, portfolio comparisons, and financial education.

Key Innovations

  • ✓First commercial insulin (Iletin)
  • ✓Polio vaccine mass production
  • ✓Prozac (fluoxetine)
  • ✓Mounjaro/Zepbound (tirzepatide)

Business Segments

  • Human Pharmaceutical Products
    Discovery and development of medicines in oncology, diabetes, immunology, and neuroscience.

How to Interpret the Results

The results shown are based on historical performance and are meant for educational and informational purposes only. They do not account for future market conditions, taxes, transaction fees, or individual investment strategies. Past performance does not guarantee future results, but historical analysis can help investors understand risk, volatility, and growth potential.

For best use:

  • Compare multiple time ranges to see how outcomes differ
  • Use consistent assumptions across different stocks
  • Combine this tool with fundamental research and diversification principles

Explore Related Stocks in Tech

Popular in Other Sectors

finance:JPMBACV|healthcare:JNJUNHPFE|consumer:WMTDISNKE|etf:SPYQQQVOO|crypto:BTC-USDETH-USD|